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Abstract
Background: Lysates from tumor cells are reported to induce maturation of dendritic cells (DCs) and are used in
clinical settings for DC-based vaccination against solid tumors. Nevertheless, the maturation inducing effect of
tumor lysates on DCs is discussed controversially and the efficacy of tumor vaccines varies significantly.
Findings: Using three individual adherent colorectal tumor cell lines we also faced the difficulty to obtain
consistent results regarding maturation inducing effect of tumor lysates on DCs. Therefore, we compared different
methods to prepare tumor cell lysate and could demonstrate that trypsinizing as a method to harvest adherent
tumor cells has a significant negative impact on biologic activity of tumor lysates. Specifically, we assessed
induction of maturation markers CD40, CD80, and CD86 on DCs which were treated with differently prepared
lysates.
Conclusions: Trypsinizing is a very common way of harvesting adherent cells from culture flasks. Our results shall
call investigators’ attention to the enzymatic activity of trypsin degrading some possibly important proteins on the
surface of cultured cells. Specifically for DC-based vaccination against tumor antigens investigators should avoid
trypsin.
Findings
Lysates from tumor cells are reported to induce matura-
tion of dendritic cells (DCs) and are used as a source for
tumor specific antigens [1,2], but as the maturation indu-
cing effect is not strong enough [3], cytokine cocktails
are added to DC cultures which are pulsed with tumor
lysate [3,4], in the clinical setting of DC-based tumor vac-
cination. We aimed to enhance the effect of tumor lysate
with regard to induction of DC maturation, but as
reported by others [3] we had to face the problem that
the tumor lysate rather did not induce DC maturation, in
terms of upregulation of surface markers CD40, CD80,
and CD86. We aimed to clarify the reason for conflicting
results concerning lysate-induced DC maturation.
Based on its protease activity trypsin cleaves cell sur-
face proteins necessary for adherence. Trypsin at
concentrations between 0.25% and 0.5% is generally
used to detach and to harvest adherent (tumor) cells at
the cost of loss of a portion of surface antigens. There-
fore, we hypothesized that trypsin may crucially impact
antigenicity of tumor lysate and subsequently its biologi-
cal activity.
By building a stable chelate with calcium ions ethyle-
nediaminetetraacetic acid (EDTA) deprives cells from
calcium which is crucial for cell adherence [5]. EDTA
can substitute for trypsin to detach adherent cells with-
out interfering with expressed surface antigens.
Results and Discussion
Lysates from tumor cells harvested by trypsin do not
induce expression of maturation markers on DCs
iDCs were stimulated for threee days with supernatants
of lysed tumor cells which have been harvested by
using trypsin, DCs which have been stimulated this
way failed to express maturation markers CD 40,
CD80, or CD86 (Figure 1). Same results were obtained
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dual colorectal tumor cell lines. Results from lysed
HCT-116 cells are shown as representative example.
Lysates from tumor cells can induce expression of
maturation markers on DCs if trypsin is replaced by EDTA
Due to its non-specific protease activity trypsin may not
only degrade proteins associated with cell adhesion but
also those cell surface proteins which are crucial for recog-
nition of tumor cells and induction of DC maturation,
thus we substituted for trypsin by using EDTA. In contrast
to lysates from trypsinized cells, lysates from tumor cells
which have been harvested by using EDTA (Figure 2) or a
scraper (data not shown) induced the upregulation of
maturation markers CD40, CD80, and CD86 on the sur-
face of DCs after three days of stimulation.
In order to convince ourselves that the maturation
inducing effect of tumor cell lysate is based on proteins
which are degraded by trypsin and not due other factors
found within tumor lysate we first exposed the lysate
from HCT-116 tumor cells (harvested by using just
EDTA) to trypsin (0.25% for 5 min) and used it after-
w a r d st os t i m u l a t eD C sf o r3d a y s ,r e s u l t sw e r ec o m -
pared to sham-treated lysates (exposed to PBS). Flow
cytometric analysis of surface maturation markers on
DCs shows abolished effect of trypsin-exposed lysate
(Figure 3).
Trypsinizing is a very common way of harvesting
adherent cells from culture flasks. Our results shall call
investigators’ attention to the enzymatic activity of tryp-
sin degrading not only proteins associated with cell
adherence but also those cell surface proteins which are
crucial for recognition of tumor cells and induction of
specific immune response. Specifically for DC-based
vaccination against tumor antigens investigators should
avoid trypsin. According to our results, we substituted
for trypsin with EDTA when harvesting DCs which
were supposed to be analyzed for expression of surface
maturation markers by FACS, appreciating the proteoly-
tic effect of trypsin some research group alternatively
pre-incubate their DCs with ice-cold PBS for 30 to 60
minutes, making it possible to harvest the DCs without
the need for further chemical treatment.
Figure 1 Tumor lysates from trypsinized tumor cells do not
induce maturation of DCs. Adherent tumor cells were harvested
by using 0.25% trypsin to detach the cells, washed and lysed in PBS
by repeated freezing and thawing. Human monocyte-derived
immature DCs were stimulated for 3 days with supernatants of
indicated concentrations of lysed tumor cells. 12 individual
experiments with lysates from 3 different cell lines (HCT-116, CACO-
2, COLO-678) were performed and results with lysates from HCT-116
cells are shown as representative example.
Figure 2 Tumor lysates from cells which have been harvested
using EDTA induce DC maturation in a dose dependent
manner. HCT-116 colorectal tumor cells were harvested by using
0.02% EDTA to detach the cells, washed and lysed in PBS by
repeated freezing and thawing. Human monocyte-derived immature
DCs were stimulated for 3 days with supernatants of indicated
concentrations of lysed tumor cells. Shown are representative results
from 6 individual experiments with lysates from 2 different cell lines
(HCT-116, CACO-2).
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Standard cell culture conditions
As standard culture media we used phenol-red free
DMEM (Gibco) supplemented with 10% human AB
serum (German Red Cross Blood Services Baden-
Württemberg-Hessen) and containing 100 U/ml peni-
cillin, 100 μg/ml streptomycin (Gibco). All cells (tumor
cells, monocytes, and DCs) were cultured in this media
and incubated in a humidified atmosphere at 37°C
with 5% CO2.
Generation of tumor cell lysates
Three colorectal tumor cell lines HCT-116, CACO-2,
COLO-678 (all from DSMZ, Germany) were cultured in
our standard media. Cells were splitted for further pas-
sages or harvested to generated lysates once they
reached a confluency of about 90%.
Tumor cells were detached by incubating the cells at
room temperature in 0.25% Trypsin (Gibco) in 0.02%
EDTA (trypsin/EDTA Sigma-Aldrich) or alternatively in
0.02% EDTA alone for 5 and 15 min, respectively. In
order to inactivate trypsin/EDTA, two parts of standard
cell culture media [containing 10% serum] per one part
of used trypsin/EDTA was added to the cell suspension.
Detached cells were washed with PBS and resuspended
in sterile PBS (Lonza) at a concentration of about 1 × 10
8
cells/ml and lysed by 5 cycles of freeze-thawing (F/T)
(-80 to 37°C). The viability following treatment was
assessed using trypan blue exclusion and was always
below 0.1%. Lysates were spun down hard (16,300 × g)
twice and the soluble supernatant was used at given
concentrations.
In some experiments obtained tumor cell lysates were
divided, one part was exposed to indicated concentra-
tions of trypsin and the other part was sham treated
with PBS. In order to inactivate trypsin, 100% human
AB serum (2× higher volume) was added to both arms
after 5 minutes. The activity of trypsin-exposed lysates
was compared to its sham-treated (PBS-exposed)
counterpart.
Isolation of peripheral blood mononuclear cells and
purification of monocytes and autologous lymphocytes
With the permission and supervision of the Institutional
Review Board (Ethical Committee) of the University of
Ulm human peripheral blood mononuclear cells were
purified from whole blood by density gradient centrifuga-
tion using Biocoll (Biochrom AG, Germany), monocytes
were positively selected using anti-CD14 antibodies
labelled with magnetic beads (Miltenyi Biotec) following
the manufacturer’s instructions. The purity was assessed
under microscope and was at least 95%.
Generation of monocyte derived human DCs
Immature DCs (iDCs) were generated from human
monocytes within 5 days in the presence of IL-4 (500
U/ml) and GM-CSF (1000 U/ml) [6] (both cytokines
from R&D Systems). iDCs were harvested by using
EDTA, resuspended in our standard media and trans-
ferred into a flat bottom 24 well plate (Nunc) at a den-
sity of 3 to 5 × 10
5 iDCs/well and ml. iDCs were
stimulated with indicated concentrations of individual
tumor cell lysates for 3 further days and harvested then
by using EDTA to detach the DCs. The mixture of IFNg
(100 ng/ml), TNFa (50 ng/ml), IL1b (10 ng/ml) (all
from R&D Systems), and LPS (100 ng/ml) (Sigma-
Aldrich) served as positive control for induction of DC
maturation.
Cell surface staining and flow cytometry
DCs were fixed in 2% paraformaldehyde (Fluka) for
2 0m i na tr o o mt e m p e r a t u r e ,w a s h e dw i t hP B S .N o n -
specific binding sites on DCs were blocked for at least
10 min with mouse whole IgG (Jackson Immuno-
Research Laboratories). Specific staining was performed
for at least 1 h at room temperature or alternatively
Figure 3 Trypsin abolishes maturation inducing effect of tumor
lysate. Lysate from HCT-116 colorectal tumor cells which have been
harvested by using 0.02% EDTA was were divided, one part was
exposed to trypsin (0.25%) and the other part was sham treated
with PBS for 5 min. In order to inactivate trypsin, 100% human AB
serum (2× higher volume) was added to both arms after 5 minutes.
DCs were stimulated for 3 days with trypsin-exposed or sham-
treated tumor lysate and examined for expression of surface
maturation markers CD40 and CD86.
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anti-human CD40, CD80 and CD86 or respective iso-
type controls (R&D Systems). The fluorescence of
stained cells was assessed using BD FACScan (BD Bios-
ciences). At least 20,000 events were acquired in all flow
cytometric analyses.
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